Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma [3]

European Respiratory Journal

Volumn 23, Issue 2, 2004, Pages 354-355

  Mohn, A ^a   Verini, M ^a   Mele, R ^a   De Leonardis, C ^a   Chiarelli, F ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; FLUTICASONE PROPIONATE; HYDROCORTISONE;

ADRENAL DISEASE; ADRENAL FUNCTION; ADRENAL SUPPRESSION; ASTHMA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; LETTER; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

EID: 1042269506     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00102803     Document Type: Letter

References (4)

1. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone proprionate in children with asthma. Eur Resp J 2003; 21: 633-636.
2. Wong JY, Zacharin MR, Hocking N, Robinson PJ. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate. J Paediatr Child Health 2002; 38: 59-62.
3. Taylor AV, Laoprasert N, Zimmermann D, Sachs MI. Adrenal suppression secondary to inhaled fluticasone propionate. Ann Allergy Asthma Immunol 1999; 83: 68-70.
4. Crowley S. Inhaled glucocorticoids and adrenal function: an update. Paediatr Resp Rev 2003; 4: 153-161.